PVLA
Palvella Therapeutics
PVLA
PVLA
60 hedge funds and large institutions have $33.4M invested in Palvella Therapeutics in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $36.7M → $33.4M (-$3.3M)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
40% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 20
Holders
60
Holding in Top 10
1
Calls
$107K
Puts
$20K
Top Buyers
| 1 | +$3.06M | |
| 2 | +$1.4M | |
| 3 | +$467K | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
+$300K |
| 5 |
OCA
Octagon Capital Advisors
New York
|
+$294K |
Top Sellers
| 1 | -$3.56M | |
| 2 | -$530K | |
| 3 | -$501K | |
| 4 |
Millennium Management
New York
|
-$464K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$380K |